Cargando…
Recent Update on Neurosurgical Management of Brain Metastasis
Brain metastasis (BM), classified as a secondary brain tumor, is the most common malignant central nervous system tumor whose median overall survival is approximately 6 months. However, the survival rate of patients with BMs has increased with recent advancements in immunotherapy and targeted therap...
Autores principales: | Yoo, Jihwan, Park, Hun Ho, Kang, Seok-Gu, Chang, Jong Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353165/ https://www.ncbi.nlm.nih.gov/pubmed/35929114 http://dx.doi.org/10.14791/btrt.2022.0023 |
Ejemplares similares
-
Prognostic factors to predict the efficacy of surgical interventions against brain metastasis secondary to thyroid cancer
por: Yoo, Jihwan, et al.
Publicado: (2022) -
Update on the Management of Brain Metastasis
por: Singh, Karanvir, et al.
Publicado: (2022) -
Recent advances in managing brain metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2018) -
Allergy identification for neurosurgical patients: updates for management
por: Liu, Annika, et al.
Publicado: (2023) -
Recent Updates on the Management of Adrenal Incidentalomas
por: Park, Seung Shin, et al.
Publicado: (2023)